Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Morel

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Emerging Infectious Diseases|March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis TreatmentValentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
The Journal of Clinical Endocrinology and Metabolism|July 12, 2014
Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathyOlivier Bourron, Carole Elodie Aubert, Sophie Liabeuf, et al.
Frontiers in Immunology|August 20, 2021
Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological MalignancyVincent Gies, Yannick Dieudonné, Florence Morel, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
Frontiers in Microbiology|June 30, 2020
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive <i>Klebsiella pneumoniae</i> in a Multi-Country CollectionMyeongjin Choi, Nicolas Hegerle, Joseph Nkeze, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Emerging Infectious Diseases|March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis TreatmentValentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
The Journal of Clinical Endocrinology and Metabolism|July 12, 2014
Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathyOlivier Bourron, Carole Elodie Aubert, Sophie Liabeuf, et al.
Frontiers in Immunology|August 20, 2021
Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological MalignancyVincent Gies, Yannick Dieudonné, Florence Morel, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
Frontiers in Microbiology|June 30, 2020
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive <i>Klebsiella pneumoniae</i> in a Multi-Country CollectionMyeongjin Choi, Nicolas Hegerle, Joseph Nkeze, et al.
Pageof 2